Explore CUMYL-PEGACLONE | TiHKAL · info

Exploring CUMYL-PEGACLONE. To explore a different substance…

Names

CUMYL-PEGACLONE
2-Cumyl-5-pentyl-γ-carbolin-1-one
SGT-151

IUPAC name

5-Pentyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one

ID 4175 · Formula C₂₅H₂₈N₂O · Molecular weight 372.503

Tags Cannabinoid

InChI InChI=1S/C25H28N2O/c1-4-5-11-17-26-21-15-10-9-14-20(21)23-22(26)16-18-27(24(23)28)25(2,3)19-12-7-6-8-13-19/h6-10,12-16,18H,4-5,11,17H2,1-3H3

InChI Key AWHWTKXMUJLSRM-UHFFFAOYSA-N This stereoisomer Any stereoisomer

SMILES CCCCCn1c2ccn(c(=O)c2c2c1cccc2)C(c1ccccc1)(C)C

ChemSpider 68003813
PubChem 134818034
Wikipedia CUMYL-PEGACLONE
Project Response Cumyl-PeGaClone (1905-18)
Project Response Cumyl-PeGaClone (1860-17)

Angerer, V; Mogler, L; Steitz, J; Bisel, P; Hess, C; Schoeder, CT; Müller, CE; Huppertz, LM; Westphal, F; Schäper, J; Auwärter, V. Structural characterization and pharmacological evaluation of the new synthetic cannabinoid CUMYL-PEGACLONE Drug Test. Anal., 1 Mar 2018, 10 (3), 597-603. 511 kB. https://doi.org/10.1002/dta.2237 MS,NMR,IR

EMCDDA. New drugs in Europe, 2017, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Aug 2017. 672 kB. #6

Banister, SD; Connor, M. The chemistry and pharmacology of synthetic cannabinoid receptor agonist new psychoactive substances: Evolution In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 191-226. 1.2 MB. https://doi.org/10.1007/164_2018_144 #105

Ernst, L; Langer, N; Bockelmann, A; Salkhordeh, E; Beuerle, T. Identification and quantification of synthetic cannabinoids in ‘spice-like’ herbal mixtures: Update of the German situation in summer 2018 Forensic Sci. Int., 1 Jan 2019, 294, 96–102. 924 kB. https://doi.org/10.1016/j.forsciint.2018.11.001 #1 MS,NMR,IR,UV

Anon. Ordinance amending the Annex to the New Psychoactive Substances Act [Neue-psychoaktive-Stoffe-Gesetz] as well as Annexes to the Narcotics Act [Betäubungsmittelgesetz] 14 Mar 2019. 704 kB. #CUMYL-PEGACLONE

Wouters, E; Walraed, J; Robertson, MJ; Meyrath, M; Szpakowska, M; Chevigné, A; Skiniotis, G; Stove, C. Assessment of biased agonism among distinct synthetic cannabinoid receptor agonist scaffolds ACS Pharmacol. Transl. Sci., 10 Apr 2020, 3 (2), 285–295. 2.0 MB. https://doi.org/10.1021/acsptsci.9b00069 #19

Alam, RM; Keating, JJ. Adding more “spice” to the pot: A review of the chemistry and pharmacology of newly emerging heterocyclic synthetic cannabinoid receptor agonists Drug Test. Anal., 1 Mar 2020, 12 (3), 297–315. 2.8 MB. https://doi.org/10.1002/dta.2752 #63 Structure 71 has a single bond where a double bond belongs

Halter, S; Pulver, B; Wilde, M; Haschimi, B; Westphal, F; Riedel, J; Pütz, M; Schönberger, T; Stoll, S; Schäper, J; Auwärter, V. Cumyl‐CBMICA: A new synthetic cannabinoid receptor agonist containing a cyclobutyl methyl side chain Drug Test. Anal., 23 Oct 2020, 13 (1), 208-216. 1.3 MB. https://doi.org/10.1002/dta.2942 #Cumyl-PEGACLONE MS,NMR,IR,other

WHO. WHO Expert Committee on Drug Dependence: Forty-third Report World Health Organization, 1 Jan 2021. 1.9 MB. #CUMYL-PEGACLONE

Alam, RM; Keating, JJ. “Walking the nitrogen around the ring”: Chemical synthesis and spectroscopic characterization of novel 4‐, 5‐, 6‐, and 7‐azaindazole analogs of the synthetic cannabinoid receptor agonist MDMB‐PINACA Drug Test. Anal., 11 Nov 2021, 14 (2), 277-297. 4.1 MB. https://doi.org/10.1002/dta.3180 #11 MS,NMR,IR,UV

Andrews, R; Jorge, R; Christie, R; Gallegos, A. From JWH‐018 to OXIZIDS: Structural evolution of synthetic cannabinoids in the European Union from 2008 to present day Drug Test. Anal., 1 Apr 2023, 15 (4), 378–387. 1.2 MB. https://doi.org/10.1002/dta.3422 #CUMYL-PeGACLONE

SGT-127

Ethylbenzyl-PeGACLONE

14344

7 Dec 2019 · · Isomer Design